Everyone is dreaming of $10+ after results...but don't forget just back in January of last year the trial results didn't hit as expected and the market overreacted. Management came out and said they still believe the numbers are good enough to get approved by the FDA but it was too late, the stock price tanked from $7.50 to $1.50. And it's taken since then for us to see above $4.
So the question is, if the numbers are the same as last years...does the market have the same reaction or does everyone believe management is right when they say a negative predictive value of 90% or better (even higher with WBC) is enough to make the FDA happy?
One thing I know, there is no middle ground with this stock (like most small pharma stocks). It will drop like a rock if the test results are not 90%+ and it will shoot up like a rocket with good results.